Lifang Huang

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2026
Hypoxia-inducible CEA-targeted CAR T-cell therapy for relapsed stage IV non-small cell lung cancer.

|Jun 24, 2026
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.

|Feb 05, 2026
Comparative Analysis of T-Cell and Bone Marrow Chimerism for Relapse Prediction in Acute Leukaemia Post-Transplantation.

Chunfeng Li, Tongyuan Liu, Ying Wan

|Jan 18, 2024
Upper gastrointestinal tract immune-related adverse events: Two cases of obstructive complications occurred in immune consolidation therapy after sequential chimeric antigen receptor T cell therapy with autologous hematopoietic stem cell transplantation for refractory/relapsed diffuse large B cell lymphoma.

Qi Zhang, Chunrui Li, Yang Cao

|Jan 16, 2023
Treatment Outcomes and Prognostic Factors in 66 Patients with Chronic Myelomonocytic Leukemia (CMML) in a Single Center.

Chao Wang, Zhiqiong Wang, Fankai Meng

|Nov 18, 2022
The diagnostic role of complete MICM-P in metastatic carcinoma of bone marrow (MCBM) presented with atypical symptoms: A 7-year retrospective study of 45 cases in a single center.

Chao Wang, Zhiqiong Wang, Xiwen Tong

Pageof 1

Frequent Collaborators

3 joint publications

Jia Wei

2 joint publications

Yicheng Zhang

1 joint publications

Chao Wang

1 joint publications

Qi Zhang